Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…
Merck & Co., Inc.
Last earnings -1.6% on 2026-04-30
Strong net margin (28.1%).
Rules-based read computed from SEC figures — no Anthropic key set. Add ANTHROPIC_API_KEY to .env.local for a full Claude analysis.
Merck & Co., Inc. shows $65.0B in FY2025 revenue (+1.3% YoY), a 28.1% net margin, and 34.7% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro$19/mo · cancel anytime
Sources: SEC EDGAR (CIK 0000310158, latest 10-Q filed 2026-05-04) · EODHD · rules-based read · as of 6/17/2026, 7:30:20 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $48.7B | $59.3B | $60.1B | $64.2B | $65.0B |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $13.0B | $14.5B | $365M | $17.1B | $18.3B |
| Diluted EPS | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 |
| Net margin | 26.8% | 24.5% | 0.6% | 26.7% | 28.1% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
58 tracked peers · median
Source: EODHD. Yield = trailing-12-month dividends ÷ price.